DCT
1:23-cv-00101
Novo Nordisk Inc. v. Mylan Pharma Inc.
General
Cause of ActionPatent Infringement
SectorBiotech
StatusOpen
Patent Owner
NPE (L)
PACER
1:23-cv-00101
Nature of Suit835 ANDA
CourtD. Delaware
Judge | Period | PO Win Rate |
|---|---|---|
02/01/23 - now | 43% |
Plaintiff
Attorney
Name | Ratings |
|---|---|
L5 A | |
L5 A | |
L5 A | |
L2 E | |
L1 D | |
L5 B | |
L4 E | |
L3 B | |
L3 C | |
L3 D | |
L1 B | |
L1 B | |
L1 C | |
-- -- -- | |
-- -- -- |
No Attorneys
Defendant
Attorney
Name | Ratings |
|---|---|
L5 A | |
L4 A | |
L4 A | |
L4 C | |
L3 C | |
L2 B | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
L3 E | |
L5 E |
No Attorneys